Pàgina inicial > Resultats de la cerca: Graham, H.
  Consells de cerca
Cerca avançada
Cerca col·leccions:
Ordena'ls per: Mostrar els resultats: Format de visualizació:
Resultats globals: 5 registres trobats en 0.02 segons.
Articles, 5 registres trobats
Articles 5 registres trobats  
1.
11 p, 5.1 MB Maize nutrient composition and the influence of xylanase addition / Melo-Durán, D. (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; Pérez Hernández, José Francisco (Universitat Autònoma de Barcelona. Servei de Nutrició i Benestar Animal) ; González-Ortiz, G. (AB Vista) ; Villagómez Estrada, Sandra (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; Bedford, Michael R (AB Vista) ; Graham, H. (AB Vista) ; Solà Oriol, David (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments)
This study assessed differences in nutrient composition, physical characteristics, and xylo-oligosaccharide content with or without xylanase treatment by maize genotype and the grain position on the cob. [...]
2021 - 10.1016/j.jcs.2020.103155
Journal of Cereal Science, Vol. 97 (january 2021) , p. 103155  
Registre complet - Creative Commons
2.
10 p, 1.4 MB Growth performance and total tract digestibility in broiler chickens fed different corn hybrids / Melo Duran, Diego Alexander (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; Pérez Hernández, José Francisco (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; González-Ortiz, Gemma (AB Vista) ; Villagómez Estrada, Sandra (Universitat Autònoma de Barcelona. Servei de Nutrició i Benestar Animal) ; Bedford, Michael R (AB Vista) ; Graham, H. (AB Vista) ; Solà Oriol, David (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments)
The aim of the present study was to investigate the variability in nutrient digestibility associated with corn genetic background and its influence on the feeding value for broiler chickens. A total of 960 1-day-old male broiler chicks (Ross 308) were distributed in eight treatments, with 12 pens per treatment and 10 birds per pen in a 42-day study. [...]
2021 - 10.1016/j.psj.2021.101218
Poultry Science, Vol. 100 (april 2021)  
Registre complet - Creative Commons
3.
13 p, 409.0 KB Efficacy and Safety of Multiple Dupilumab Dose Regimens After Initial Successful Treatment in Patients With Atopic Dermatitis / Worm, Margitta ; Simpson, Eric L. (Oregon Health & Science University, Portland) ; Thaçi, Diamant (University of Lübeck, Germany) ; Bissonnette, Robert (Innovaderm Research (Montreal, Canadà)) ; Lacour, Jean Philippe (Nice University Hospital (Niça, França)) ; Beissert, Stefan (Technische Universität Dresden, Germany) ; Kawashima, Makoto (Tokyo Women's Medical University, School of Medicine, Tokyo, Japan) ; Ferrándiz, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Smith, Catherine H. (King's College London) ; Beck, Lisa (University of Rochester Medical Center, New York) ; Chan, Kuo-Chen (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Chen, Zhen (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Akinlade, Bolanle (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Hultsch, Thomas (Sanofi Genzyme, Cambridge, Massachusetts) ; Staudinger, Heribert (Sanofi, Bridgewater, New Jersey) ; Gadkari, Abhijit (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Eckert, Laurent (Sanofi, Chilly-Mazarin, France) ; Davis, John D. (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Rajadhyaksha, Manoj (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Graham, Neil M. H. (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Pirozzi, Gianluca (Sanofi, Bridgewater, New Jersey) ; Stahl, Neil (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Yancopoulos, George D. (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Ardeleanu, Marius (Regeneron Pharmaceuticals, Inc, Tarrytown, New York) ; Universitat Autònoma de Barcelona. Departament de Medicina
The dupilumab regimen of 300 mg every 2 weeks is approved for uncontrolled, moderate to severe atopic dermatitis (AD). To assess the efficacy and safety of different dupilumab regimens in maintaining response after 16 weeks of initial treatment. [...]
2019 - 10.1001/jamadermatol.2019.3617
JAMA Dermatology, Vol. 156 (december 2019) , p. 131-143  
Registre complet - Creative Commons
4.
22 p, 769.8 KB Influence of particle size and xylanase in corn-soybean pelleted diets on performance, nutrient utilization, microbiota and short-chain fatty acid production in young broilers / Melo Duran, Diego Alexander (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; González-Ortiz, Gemma (AB Vista. Marlborough) ; Sala Pallarés, Roser (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; Villagómez Estrada, Sandra (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; Bedford, Michael R. (AB Vista. Marlborough) ; Graham, Hadden (AB Vista. Marlborough) ; Solà Oriol, David (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments) ; Pérez Hernández, José Francisco (Universitat Autònoma de Barcelona. Departament de Ciència Animal i dels Aliments)
The objective of this study was to investigate the effects of particle size and xylanase supplementation in corn-based pellet diets on the performance and digestive traits in young broilers. A total of 512 male Ross 308 broilers were used in a 21-day study. [...]
2020 - 10.3390/ani10101904
Animals, Vol. 10 Núm. 10 (2020) , p. 1904  
Registre complet - Creative Commons
5.
14 p, 1.3 MB Infections in Dupilumab Clinical Trials in Atopic Dermatitis : A Comprehensive Pooled Analysis / Eichenfield, Lawrence (Division of Pediatric and Adolescent Dermatology. Rady Children's Hospital) ; Bieber, T. (Department of Dermatology and Allergy. Christine Kühne-Center for Allergy Research and Education. University of Bonn) ; Beck, Lisa (University of Rochester Medical Center. Department of Dermatology) ; Simpson, E. L. (Oregon Health and Science University. Department of Dermatology) ; Thaçi, Diamant (Universitätsklinikum Schleswig-Holstein (Alemanya)) ; de Bruin-Weller, Marjolein (University Medical Center Utrecht) ; Deleuran, Mette (Aarhus University Hospital (Aarhus, Dinamarca)) ; Silverberg, J. I. (Northwestern University Feinberg School of Medicine) ; Ferrándiz, Carlos (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ; Fölster-Holst, R. (University Hospital Schleswig-Holstein. Dermatology) ; Chen, Z. (Regeneron Pharmaceuticals. Inc.) ; Graham, N. M. H. (Regeneron Pharmaceuticals. Inc.) ; Pirozzi, G. (Sanofi) ; Akinlade, Bolanle (Regeneron Pharmaceuticals. Inc.) ; Yancopoulos, G. D. (Regeneron Pharmaceuticals. Inc.) ; Ardeleanu, Marius (Regeneron Pharmaceuticals. Inc.) ; Universitat Autònoma de Barcelona
Background: Patients with moderate-to-severe atopic dermatitis (AD) have increased infection risk, including skin infections and systemic infections. Immunomodulators (e. g. , anti-tumor necrosis factors, anti-interleukin [anti-IL]-23, anti-IL-17, Janus kinase inhibitors) increase risk of infections. [...]
2019 - 10.1007/s40257-019-00445-7
American Journal of Clinical Dermatology, Vol. 20 Núm. 3 (january 2019) , p. 443-456  
Registre complet - Creative Commons

Vegeu també: autors amb noms similars
2 Graham, Hadden
Us interessa rebre alertes sobre nous resultats d'aquesta cerca?
Definiu una alerta personal via correu electrònic o subscribiu-vos al canal RSS.
Dipòsit Digital de Documents de la UAB :: Cerca :: Lliura :: Personalitza :: Ajuda
Powered by Invenio v1.1.6
Mantingut per ddd.bib@uab.cat  :: Metadades subjectes a:
Col·laborem